irinotecan has been researched along with Cystadenocarcinoma, Mucinous in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kanishi, Y; Kiguchi, K; Kobayashi, Y; Kondo, H; Okuma, Y; Saito, K; Sato, S | 1 |
1 other study(ies) available for irinotecan and Cystadenocarcinoma, Mucinous
Article | Year |
---|---|
Establishment and characterization of a cell-line originated from human mucinous cystadenocarcinoma of the ovary.
Topics: Animals; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Agents; Biomarkers, Tumor; Camptothecin; Cell Culture Techniques; Cell Division; Cisplatin; Cystadenocarcinoma, Mucinous; Drug Screening Assays, Antitumor; Female; Humans; Irinotecan; Karyotyping; Mice; Mice, Nude; Middle Aged; Neoplasm Transplantation; Ovarian Neoplasms; Tumor Cells, Cultured | 2002 |